Intellectual Property

  • March 25, 2025

    Doctor Defends Exam Saying Judge Newman Is Fit To Serve

    A neurosurgeon who examined Federal Circuit Judge Pauline Newman and declared her fit to serve on the bench pushed back Tuesday on criticism of his evaluation made by doctors retained by the appeals court's other judges, who have suspended the 97-year-old jurist.

  • March 25, 2025

    Meta Says Using Authors' Books For AI Training Is Fair Use

    Meta Platforms has urged a California federal judge to find that it did not violate copyright law in using material from books by more than a dozen authors to train its large language models named "Llama," saying the dispute "presents a question of existential importance" to the development of generative artificial intelligence in the U.S.

  • March 25, 2025

    Baker Botts Atty Says Patent Exec Can't Prove Defamation

    A Baker Botts LLP lawyer is contending that a Florida federal court cannot side with a patent-licensing company executive on his defamation claim against the attorney over her comments in a news article about a patent suit against Starbucks, saying she didn't say anything false.

  • March 25, 2025

    Retired Texas Federal Judge Joins Shook Hardy

    Shook Hardy & Bacon LLP announced Tuesday that a retired U.S. magistrate judge for Texas' Eastern District has joined its complex litigation strategic counseling practice, boosting the firm's ability nationwide to handle class actions, governmental investigations and intellectual property matters.

  • March 25, 2025

    Womble Bond Atty's Contempt Order Isn't Final, 4th Circ. Told

    A federal judge's order holding a Womble Bond Dickinson partner in contempt of court over misrepresentations he allegedly made to a foreign tribunal isn't a final decision capable of being appealed, a software company told the Fourth Circuit in seeking to have the appeal tossed.

  • March 25, 2025

    Coffee Drink Co. Asks Justices To Review TM Fight With Pepsi

    A company that makes nitro-brewed coffee drinks called "Rise" has asked the U.S. Supreme Court to answer whether the strength of a trademark is a question of law to be decided by judges after the Second Circuit affirmed the dismissal of a lawsuit against PepsiCo.

  • March 24, 2025

    Limp Bizkit Expands UMG Royalties Fight To State Court

    Limp Bizkit, lead singer Fred Durst and their record label launched a second front against Universal Music Group in California state court over claims that its "royalty software" has shorted artists more than $200 million, after a federal judge ruled he couldn't oversee the bulk of the claims.

  • March 24, 2025

    Justices Told To Eye TM Time Limits In Samsung Unit Feud

    After seeing its trademark lawsuit against a Samsung subsidiary transferred to a court where the case was outside the statute of limitations, a small New Jersey company that sells electronics accessories now wants the nation's highest court to address trademark law's "patchwork of inconsistent limitations periods."

  • March 24, 2025

    Google Wins Sanctions For Ramey Firm's 'Baseless' IP Suit

    A New York federal magistrate judge granted Google's request Monday for sanctions against Ramey LLP for filing an allegedly "baseless" suit on behalf of EscapeX IP accusing YouTube of infringing its social media chat-function patent, finding that counsel failed to conduct a presuit investigation and needlessly drew out litigation.

  • March 24, 2025

    Kimmel's Use Of Santos Videos Not Fair, 2nd Circ. Told

    Cameo videos recorded by former U.S. Rep. George Santos were designed to be satirical jokes, and their rebroadcast by ABC comedian Jimmy Kimmel was not a transformative work protected by the copyright law's fair use doctrine, Santos' attorney told the Second Circuit on Monday.

  • March 24, 2025

    Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out

    Amgen has urged a Delaware federal court to grant it a new trial after a federal jury last year found that it owed Germany's Lindis Biotech $50.3 million in damages for encouraging healthcare providers to infringe immunotherapy patents by administering a leukemia treatment.

  • March 24, 2025

    Justices Urged To Weigh In On Skinny Label Dispute

    A generic-drug industry organization and a group of scholars are urging the U.S. Supreme Court to scrutinize a Federal Circuit decision they say undermines the process for getting generic drugs to market under so-called skinny labels.

  • March 24, 2025

    Fed. Circ. Affirms Invalidity Finding In Tape Patent Fight

    The Federal Circuit on Monday backed a lower court's finding that a patent covering a type of marking tape was invalid as anticipated, while also mostly upholding a sanctions award that tape manufacturer ShieldMark secured in the case accusing it of infringement.

  • March 24, 2025

    Fed. Circ. Cuts $2.6M From $10M Car Wash Patent Verdict

    The Federal Circuit on Monday cut nearly $2.6 million from an over $10 million verdict against Wash World Inc. for infringing a rival's car wash patent, saying that part of the award involved products unrelated to the patent, but refused to undo the infringement finding.

  • March 24, 2025

    Judge OKs NIL Recruiting Rules Deal​​​​​​​ Between States, NCAA

    A Tennessee federal judge has signed off on a settlement that resolves antitrust litigation over the NCAA's practice of banning the use of possible name, image and likeness compensation when recruiting athletes.

  • March 24, 2025

    Fed. Circ. Reverses PTAB Decision On Logistics Patent App

    The Federal Circuit ruled Monday that it disagreed with how the Patent Trial and Appeal Board interpreted legal precedent on prior art, telling it to take another look at a patent application covering early online innovations in the freight transit sector that was filed more than two decades ago.

  • March 24, 2025

    Apple, Sony, Others Facing ITC Probes Over Imports

    The U.S. International Trade Commission has said it is launching a series of investigations into whether imports of products such as video game consoles, nose cleaning devices and semiconductors have infringed various U.S. patents.

  • March 24, 2025

    No $1M Placeholder In 'Black Widow' TM Feud, Judge Rules

    A Connecticut federal judge will not require a pest control company to post more than $1 million to cover potential damages in a trademark lawsuit over the name "Black Widow," which is also the subject of a paused cancellation proceeding before the U.S. Patent and Trademark Office.

  • March 24, 2025

    TTAB Denies Jack's Grill TM Over Confusion With Chain

    The Trademark Trial and Appeal Board has denied an attempt by a California restaurant called Jack's Grill and Billiards Inc. to register its name, saying it would likely create confusion with Jack's Family Restaurants, a chain that has hundreds of locations in Alabama, Georgia, Mississippi and Tennessee.

  • March 24, 2025

    Trump Asks High Court To Halt Fed. Workers' Reinstatement

    The Trump administration asked the U.S. Supreme Court on Monday to pause a California federal court order reinstating tens of thousands of probationary federal workers who were fired from six agencies, arguing the band of nonprofit groups that obtained the order have no standing to challenge the firings.

  • March 24, 2025

    Netlist Again Wins Samsung Patent Contract Suit On Retrial

    Netlist Inc. secured a repeat win Monday in a California federal court retrial of a breach of contract suit against Samsung Electronics Co., a verdict that itself carries no money judgment but bolsters the chipmaker's position on maintaining $421 million worth of patent infringement damages from separate trials.

  • March 24, 2025

    Dog Toy Maker Appeals Injunction In Jack Daniel's TM Dispute

    The maker of a poop-themed dog toy that mimics Jack Daniel's bottles is appealing a permanent injunction that an Arizona federal court entered after finding the company tarnished the whiskey-maker's brand by associating it with feces.

  • March 24, 2025

    Supreme Court Skips Fed. Circ. 1-Word Order Cases

    The U.S. Supreme Court on Monday rejected a pair of challenges to the Federal Circuit's use of one-word orders in patent cases.

  • March 24, 2025

    High Court Turns Down Case Over Amazon Patent Program

    The U.S. Supreme Court decided Monday not to hear an appeal of a Federal Circuit decision that found a company alleging patent infringement through Amazon's patent evaluation program must face a declaratory judgment suit in the accused infringer's home state.

  • March 24, 2025

    Supreme Court Won't Review Dismissal Of Koss' PTAB Appeal

    The U.S. Supreme Court on Monday turned down an appeal by headphone maker Koss Corp. arguing that the Federal Circuit wrongly dismissed its appeal of a Patent Trial and Appeal Board decision by finding that the company's patents had been declared invalid in a separate case that settled.

Expert Analysis

  • Opinion

    New DOJ Leaders Should Curb Ill-Conceived Prosecutions

    Author Photo

    First-of-their-kind cases have seemingly led to a string of overly aggressive prosecutions in recent years, so newly sworn-in leaders of the U.S. Department of Justice should consider creating reporting channels to stop unwise prosecutions before they snowball, says Jonathan Porter at Husch Blackwell.

  • Opinion

    Judge Should Not Have Been Reprimanded For Alito Essay

    Author Photo

    Senior U.S. District Judge Michael Ponsor's New York Times essay critiquing Supreme Court Justice Samuel Alito for potential ethical violations absolutely cannot be construed as conduct prejudicial to the administration of the business of the courts, says Ashley London at the Thomas R. Kline School of Law of Duquesne University.

  • A Look At Drug Price Negotiation Program's Ongoing Impact

    Author Photo

    More than two years after the passage of the Inflation Reduction Act and the rapid implementation of the drug price negotiation program, attorneys at Ropes & Gray discuss how the IRA has influenced licensing strategies, and how maximum fair prices under the law have economically affected certain drugs.

  • Opinion

    Congress Must Consider Accurate Data About Patent Thickets

    Author Photo

    If Congress revisits a controversial bill this year aimed at limiting the number of patents pharmaceutical manufacturers could assert, it must make sure to act based on accurate reports — such as a recent U.S. Patent and Trademark Office study that found no evidence of patent thicketing, says David Kappos at the Council for Innovation Promotion.

  • Lights, Camera, Ethics? TV Lawyers Tend To Set Bad Example

    Author Photo

    Though fictional movies and television shows portraying lawyers are fun to watch, Hollywood’s inaccurate depictions of legal ethics can desensitize attorneys to ethics violations and lead real-life clients to believe that good lawyers take a scorched-earth approach, says Nancy Rapoport at the University of Nevada, Las Vegas.

  • Opinion

    DOGE Should Address Inefficiency In The Patent Marketplace

    Author Photo

    Elon Musk's Department of Government Efficiency is well positioned to identify to Congress the necessary variability needed among individual patent rights, ensuring that the U.S. Patent and Trademark Office's current inefficiencies do not impede promising inventions from reaching the market, says John Powers at Powers IP.

  • Perspectives

    Accountant-Owned Law Firms Could Blur Ethical Lines

    Author Photo

    KPMG’s recent application to open a legal practice in Arizona represents the first overture by an accounting firm to take advantage of the state’s relaxed law firm ownership rules, but enforcing and supervising the practice of law by nonattorneys could prove particularly challenging, says Seth Laver at Goldberg Segalla.

  • AI Will Soon Transform The E-Discovery Industrial Complex

    Author Photo

    Todd Itami at Covington discusses how generative artificial intelligence will reshape the current e-discovery paradigm, replacing the blunt instrument of data handling with a laser scalpel of fully integrated enterprise solutions — after first making e-discovery processes technically and legally harder.

  • IP, Licensing, M&A Trends To Watch In Life Sciences This Year

    Author Photo

    2025 promises to continue an exciting trajectory for the life sciences industry, with major trends ranging from global harmonization of intellectual property to cross-border licensing activity and an increase of nontraditional financial participants in the mergers and acquisition space, say attorneys at Morgan Lewis.

  • When Innovation Overwhelms The Rule Of Law

    Author Photo

    In an era where technology is rapidly evolving and artificial intelligence is seemingly everywhere, it’s worth asking if the law — both substantive precedent and procedural rules — can keep up with the light speed of innovation, says Reuben Guttman at Guttman Buschner.

  • Drug Pricing Policy Trends To Expect In 2025 And Beyond

    Author Photo

    Though 2025 may bring more of the same in the realm of drug pricing policy, business as usual entails a sustained, high level of legal and policy developments across at least six major areas, say attorneys at Ropes & Gray.

  • Imagine The Possibilities Of Openly Autistic Lawyering

    Author Photo

    Andi Mazingo at Lumen Law, who was diagnosed with autism about midway through her career, discusses how the legal profession can create inclusive workplaces that empower openly autistic lawyers and enhance innovation, and how neurodivergent attorneys can navigate the challenges and opportunities that come with disclosing one’s diagnosis.

  • Opinion

    Courts Should Nix Conferencing Rule In 1 Discovery Scenario

    Author Photo

    Parties are generally required to meet and confer to resolve a discovery dispute before bringing a related motion, but courts should dispense with this conferencing requirement when a party fails to specify a time by which it will complete its production, says Tristan Ellis at Shanies Law.

  • Series

    Documentary Filmmaking Makes Me A Better Lawyer

    Author Photo

    Becoming a documentary filmmaker has allowed me to merge my legal expertise with my passion for storytelling, and has helped me to hone negotiation, critical thinking and problem-solving skills that are important to both endeavors, says Robert Darwell at Sheppard Mullin.

  • Litigation Funding Disclosure Debate: Strategy Considerations

    Author Photo

    In the ongoing debate over whether courts should require disclosure of litigation funding, funders and plaintiffs tend to argue against such mandates, but voluntarily disclosing limited details about a funding arrangement can actually confer certain benefits to plaintiffs in some scenarios, say Andrew Stulce and Marc Cavan at Longford Capital.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!